Genedrive plc
Company Profile
Genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications.
The Company has assays on the market for the detection of MT-RNR1, HCV, certain military biological targets, a high throughput SARS-CoV-2 assay and a point of care test for Covid-19.
The company are currently developing a genetic test for CYP2C19 metaboliser status.

Latest Company Summary
Investor Access
2023 Annual General Meeting
(please check the link for more information: https://www.londonstockexchange.com/news-article/GDR/publication-of-circular-and-notice-of-gm/15928902)Thursday, 11 May 2023 at 11.00am
Event | Date |
Year End | 30 June |
Half Year End | 31 December |
Preliminary Results | November |
Interim Results* | March |
AGM* | May |
* Months based on previous announcements of this kind